(AVY) Avery Dennison - Overview
Stock: Label Materials, Performance Tapes, Graphics Films, Branding Tags, RFID
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.11% |
| Yield on Cost 5y | 2.30% |
| Yield CAGR 5y | 8.60% |
| Payout Consistency | 96.2% |
| Payout Ratio | 52.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.8% |
| Relative Tail Risk | -4.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -3.53 |
| Character TTM | |
|---|---|
| Beta | 0.583 |
| Beta Downside | 0.461 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.72% |
| CAGR/Max DD | 0.12 |
Description: AVY Avery Dennison January 02, 2026
Avery Dennison Corp. (NYSE: AVY) is a global materials-science and digital-identification company that markets pressure-sensitive label materials, performance tapes, graphics/reflective films, and branding & information solutions (e.g., RFID, brand-protection tags) across a broad customer base that includes retail, e-commerce, logistics, food & grocery, pharma, and automotive.
Key operating metrics (FY 2023): revenue ≈ $10.1 billion, adjusted EPS ≈ $4.44, and a 12 % YoY increase in the RFID-based information-solutions segment, which now contributes roughly 18 % of total sales. The company’s “sustainable packaging” portfolio grew at a 15 % compound annual rate over the past three years, reflecting rising consumer and regulatory pressure for recyclable and low-carbon materials.
Sector drivers that materially affect AVY’s outlook include (1) accelerating demand for eco-friendly packaging driven by EU and U.S. legislation on single-use plastics; (2) expanding adoption of item-level RFID in supply-chain visibility, especially within the fast-growing e-commerce and logistics markets; and (3) raw-material cost volatility (primarily petroleum-derived plastics) that can compress margins unless offset by pricing power or cost-efficiency initiatives.
Investors should monitor the company’s ability to translate its RFID and sustainable-packaging growth into higher-margin revenue streams while managing input-cost pressures.
For a concise, data-rich overview of AVY’s valuation and risk profile, the ValueRay platform provides a quick reference worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 695.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.13 > 1.0 |
| NWC/Revenue: 8.40% < 20% (prev -3.04%; Δ 11.44% < -1%) |
| CFO/TA 0.10 > 3% & CFO 855.8m > Net Income 695.6m |
| Net Debt (3.24b) to EBITDA (1.41b): 2.31 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.3m) vs 12m ago -3.09% < -2% |
| Gross Margin: 28.56% > 18% (prev 0.29%; Δ 2827 % > 0.5%) |
| Asset Turnover: 101.3% > 50% (prev 102.7%; Δ -1.43% > 0%) |
| Interest Coverage Ratio: 8.53 > 6 (EBITDA TTM 1.41b / Interest Expense TTM 127.4m) |
Altman Z'' 4.22
| A: 0.08 (Total Current Assets 3.52b - Total Current Liabilities 2.79b) / Total Assets 8.87b |
| B: 0.62 (Retained Earnings 5.50b / Total Assets 8.87b) |
| C: 0.13 (EBIT TTM 1.09b / Avg Total Assets 8.66b) |
| D: 0.78 (Book Value of Equity 5.17b / Total Liabilities 6.66b) |
| Altman-Z'' Score: 4.22 = AA |
Beneish M -3.03
| DSRI: 1.02 (Receivables 1.63b/1.57b, Revenue 8.77b/8.68b) |
| GMI: 1.02 (GM 28.56% / 29.00%) |
| AQI: 0.96 (AQ_t 0.42 / AQ_t-1 0.44) |
| SGI: 1.01 (Revenue 8.77b / 8.68b) |
| TATA: -0.02 (NI 695.6m - CFO 855.8m) / TA 8.87b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of AVY shares?
Over the past week, the price has changed by +4.47%, over one month by +6.97%, over three months by +11.35% and over the past year by +8.02%.
Is AVY a buy, sell or hold?
- StrongBuy: 4
- Buy: 3
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AVY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 206.8 | 7.1% |
| Analysts Target Price | 206.8 | 7.1% |
| ValueRay Target Price | 197.8 | 2.4% |
AVY Fundamental Data Overview February 04, 2026
P/E Forward = 17.5747
P/S = 1.6489
P/B = 6.4853
P/EG = 1.7639
Revenue TTM = 8.77b USD
EBIT TTM = 1.09b USD
EBITDA TTM = 1.41b USD
Long Term Debt = 3.20b USD (from longTermDebt, last quarter)
Short Term Debt = 578.8m USD (from shortTermDebt, last quarter)
Debt = 3.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.24b USD (from netDebt column, last quarter)
Enterprise Value = 17.71b USD (14.46b + Debt 3.78b - CCE 534.4m)
Interest Coverage Ratio = 8.53 (Ebit TTM 1.09b / Interest Expense TTM 127.4m)
EV/FCF = 25.87x (Enterprise Value 17.71b / FCF TTM 684.4m)
FCF Yield = 3.86% (FCF TTM 684.4m / Enterprise Value 17.71b)
FCF Margin = 7.80% (FCF TTM 684.4m / Revenue TTM 8.77b)
Net Margin = 7.93% (Net Income TTM 695.6m / Revenue TTM 8.77b)
Gross Margin = 28.56% ((Revenue TTM 8.77b - Cost of Revenue TTM 6.27b) / Revenue TTM)
Gross Margin QoQ = 28.66% (prev 28.78%)
Tobins Q-Ratio = 2.00 (Enterprise Value 17.71b / Total Assets 8.87b)
Interest Expense / Debt = 0.88% (Interest Expense 33.3m / Debt 3.78b)
Taxrate = 29.17% (68.5m / 234.8m)
NOPAT = 769.2m (EBIT 1.09b * (1 - 29.17%))
Current Ratio = 1.26 (Total Current Assets 3.52b / Total Current Liabilities 2.79b)
Debt / Equity = 1.71 (Debt 3.78b / totalStockholderEquity, last quarter 2.21b)
Debt / EBITDA = 2.31 (Net Debt 3.24b / EBITDA 1.41b)
Debt / FCF = 4.74 (Net Debt 3.24b / FCF TTM 684.4m)
Total Stockholder Equity = 2.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.03% (Net Income 695.6m / Total Assets 8.87b)
RoE = 31.28% (Net Income TTM 695.6m / Total Stockholder Equity 2.22b)
RoCE = 20.02% (EBIT 1.09b / Capital Employed (Equity 2.22b + L.T.Debt 3.20b))
RoIC = 13.47% (NOPAT 769.2m / Invested Capital 5.71b)
WACC = 6.52% (E(14.46b)/V(18.24b) * Re(8.06%) + D(3.78b)/V(18.24b) * Rd(0.88%) * (1-Tc(0.29)))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.68%
[DCF Debug] Terminal Value 83.43% ; FCFF base≈667.2m ; Y1≈646.3m ; Y5≈642.2m
Fair Price DCF = 164.5 (EV 15.96b - Net Debt 3.24b = Equity 12.72b / Shares 77.3m; r=6.52% [WACC]; 5y FCF grow -4.29% → 2.90% )
EPS Correlation: 26.31 | EPS CAGR: 2.89% | SUE: 0.54 | # QB: 0
Revenue Correlation: -15.71 | Revenue CAGR: 0.39% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.40 | Chg30d=-0.027 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=10.42 | Chg30d=-0.136 | Revisions Net=-2 | Growth EPS=+9.8% | Growth Revenue=+4.8%